Gene therapy for heart failure: where do we stand? - Wikidata - awgldk - TriplyDB

Gene therapy for heart failure: where do we stand?

Gene therapy for heart failure: where do we stand?

http://www.wikidata.org/entity/Q38073152

about

Structural Dynamics and Topology of Phosphorylated Phospholamban Homopentamer Reveal Its Role in the Regulation of Calcium Transport

P2860

Q27680562-864923B0-04ED-4350-97E4-63B755B54D74

P2860

Gene therapy for heart failure: where do we stand?

http://www.wikidata.org/entity/Q38073152

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Gene therapy for heart failure: where do we stand?

@en

type

label

Gene therapy for heart failure: where do we stand?

@en

prefLabel

Gene therapy for heart failure: where do we stand?

@en

P1433

Q38073152-2BFD2349-851C-40BA-B3BD-CF1F6CB340E4

P1476

Q38073152-441CB057-DDEF-4D1A-B8A6-9150A2826392

P2093

Q38073152-00AC62EE-5C9C-426A-9C32-6FB0C9F6081C

Q38073152-AA120E63-41DB-492A-938B-2004C62AE583

P2860

Q38073152-02CBCD89-742E-45D6-88EA-16145F278061

Q38073152-05E43DF9-53A7-4ABB-841B-6181BD57AB2A

Q38073152-079F0002-FA68-4824-B52D-295FDCA47835

Q38073152-0E549B49-A829-4F9F-96BD-80580DFB874D

Q38073152-0F84A0EE-59C4-41AB-A530-61834BDFD12E

Q38073152-15A916D6-C841-4134-9DC7-B8DAFE63720F

Q38073152-16ED5AF7-763C-4B9D-9EE5-09BEFF4D8F62

Q38073152-17511FB9-A4A4-4074-BB3A-FF7BFF3947CD

Q38073152-17535BD6-69BC-4A6C-BAB0-2320EB9873BF

Q38073152-18085F3E-D732-48CC-83C2-26DBBBC85D44

P2888

Q38073152-8340AB5B-CD23-4346-9970-5EE4177C8474

P304

Q38073152-AADACC80-C4D9-4100-AC30-58C05F537EB9

P31

Q38073152-7F7DCC63-C3B4-4E9B-948C-F8C74E2A3F3D

P356

Q38073152-99BBAEEB-D60A-45C5-9838-6EAAD4A3A888

P433

Q38073152-1D56D545-C8DC-43EB-9D25-3B85E0B641E1

P478

Q38073152-C655B6D6-9A0B-4F72-A64A-C5C348F1A2B2

P50

Q38073152-B48B7BA0-514C-4839-9404-7BE2638DE02D

P577

Q38073152-B5A14BD0-34D6-4F7E-BBF9-49B815160F80

P6179

Q38073152-2C021EB1-08F0-47F0-AFAB-FE6400083123

P698

Q38073152-7D0E4556-2BB7-4FFA-AC9D-32EC90551C93

P921

Q38073152-2EB6CBBB-A582-4199-91EC-CCB8F8AF5F56

P932

Q38073152-DB8C9826-76AF-42E4-BB6C-8DFFFE919B5C

P356

S11886-012-0333-3

P1433

Current cardiology reports

P1476

Gene therapy for heart failure: where do we stand?

@en

P2093

Armen Yerevanian

http://www.w3.org/2001/XMLSchema#string

Roger J Hajjar

http://www.w3.org/2001/XMLSchema#string

P2860

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a.

Gene transfer in humans using a conditionally replicating lentiviral vector

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

SUMO1-dependent modulation of SERCA2a in heart failure.

CXCR4 modulates contractility in adult cardiac myocytes

Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.

P2888

s11886-012-0333-3

P304

333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-012-0333-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038126887

http://www.w3.org/2001/XMLSchema#string

P698

23307169

http://www.w3.org/2001/XMLSchema#string

P921

P932

3562543

http://www.w3.org/2001/XMLSchema#string